Lymphoma Archives - Insights https://news.mayocliniclabs.com/category/hematology/lymphoma/ Get the latest news and education from Mayo Clinic Laboratories Thu, 20 Feb 2025 21:05:07 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.1 Specialized testing helps reverse effects of stiff-person syndrome: James Kypuros https://news.mayocliniclabs.com/2023/12/11/specialized-testing-helps-reverse-effects-of-stiff-person-syndrome-james-kypuros/ https://news.mayocliniclabs.com/2023/12/11/specialized-testing-helps-reverse-effects-of-stiff-person-syndrome-james-kypuros/#respond Mon, 11 Dec 2023 14:00:00 +0000 https://news.mayocliniclabs.com/?p=106916 Specialized testing helps reverse effects of stiff-person syndrome: James KypurosOne summer morning, James Kypuros awoke to find his toes stiffened like claws. Then he started having falls, which culminated in losing his ability to walk or even sit up without help. Diagnosed with stiff-person syndrome, James wouldn’t find hope or relief until he was treated for glycine receptor antibody syndrome following specialized testing by Mayo Clinic.

The post Specialized testing helps reverse effects of stiff-person syndrome: James Kypuros appeared first on Insights.

]]> https://news.mayocliniclabs.com/2023/12/11/specialized-testing-helps-reverse-effects-of-stiff-person-syndrome-james-kypuros/feed/ 0 RNA test identifies large B-cell lymphoma subtypes: Lisa Rimsza, M.D. https://news.mayocliniclabs.com/2023/11/14/rna-test-identifies-large-b-cell-lymphoma-subtypes-lisa-rimsza-m-d/ https://news.mayocliniclabs.com/2023/11/14/rna-test-identifies-large-b-cell-lymphoma-subtypes-lisa-rimsza-m-d/#respond Tue, 14 Nov 2023 14:00:00 +0000 https://news.mayocliniclabs.com/?p=102194 RNA test identifies large B-cell lymphoma subtypes: Lisa Rimsza, M.D.Lisa Rimsza, M.D., explains how Mayo Clinic Laboratories' unique PM3CX test can accurately determine subtypes of large B-cell lymphoma. Precise diagnosis is critical to choosing appropriate chemotherapy.

The post RNA test identifies large B-cell lymphoma subtypes: Lisa Rimsza, M.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2023/11/14/rna-test-identifies-large-b-cell-lymphoma-subtypes-lisa-rimsza-m-d/feed/ 0 T-cell Lymphoma [Test in Focus] https://news.mayocliniclabs.com/2021/09/21/t-cell-lymphoma-a-test-in-focus/ https://news.mayocliniclabs.com/2021/09/21/t-cell-lymphoma-a-test-in-focus/#respond Tue, 21 Sep 2021 12:45:00 +0000 https://news.mayocliniclabs.com/?p=79690 T-cell Lymphoma [Test in Focus]Andrew Feldman, M.D., discusses the different tools and techniques Mayo Clinic Laboratories uses to accurately diagnose and classify T-cell lymphomas to help provide clinicians with the diagnostic answers they need to treat their patients.

The post T-cell Lymphoma [Test in Focus] appeared first on Insights.

]]> https://news.mayocliniclabs.com/2021/09/21/t-cell-lymphoma-a-test-in-focus/feed/ 0 TRBC1 a Useful Tool in T-Cell Flow Cytometry [Test in Focus] https://news.mayocliniclabs.com/2020/08/11/tcrbc1-a-useful-tool-in-t-cell-flow-cytometry-a-test-in-focus/ https://news.mayocliniclabs.com/2020/08/11/tcrbc1-a-useful-tool-in-t-cell-flow-cytometry-a-test-in-focus/#respond Tue, 11 Aug 2020 14:30:00 +0000 https://news.mayocliniclabs.com/?p=64780 TRBC1 a Useful Tool in T-Cell Flow Cytometry [Test in Focus]Horatiu Olteanu, M.D., Ph.D., gives an overview of the new T-cell receptor (TCR) β-chain constant region (TRBC1) flow cytometry marker, which is now included in Mayo Clinic Laboratories' routine diagnostic T-cell flow cytometry panel. He discusses when this testing should be ordered, how the addition of TCRBC1 compares to previous testing approaches, and how this marker can assist ordering physicians.

The post TRBC1 a Useful Tool in T-Cell Flow Cytometry [Test in Focus] appeared first on Insights.

]]> https://news.mayocliniclabs.com/2020/08/11/tcrbc1-a-useful-tool-in-t-cell-flow-cytometry-a-test-in-focus/feed/ 0 IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL) https://news.mayocliniclabs.com/2019/08/12/ighv-and-tp53-sequencing-clinical-utility-in-chronic-lymphocytic-leukemia-cll/ https://news.mayocliniclabs.com/2019/08/12/ighv-and-tp53-sequencing-clinical-utility-in-chronic-lymphocytic-leukemia-cll/#respond Mon, 12 Aug 2019 12:30:01 +0000 https://news.mayocliniclabs.com/?p=53459 <em>IGHV</em> and <em>TP53</em> Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL)In this month’s “Hot Topic,” Curtis Hanson, M.D., will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53 sequencing in these patients.

The post <em>IGHV</em> and <em>TP53</em> Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL) appeared first on Insights.

]]> https://news.mayocliniclabs.com/2019/08/12/ighv-and-tp53-sequencing-clinical-utility-in-chronic-lymphocytic-leukemia-cll/feed/ 0 Curtis Hanson, M.D., Discusses Prognostic Markers for Chronic Lymphocytic Leukemia https://news.mayocliniclabs.com/2019/06/06/curtis-hanson-m-d-discusses-prognostic-markers-for-chronic-lymphocytic-leukemia/ https://news.mayocliniclabs.com/2019/06/06/curtis-hanson-m-d-discusses-prognostic-markers-for-chronic-lymphocytic-leukemia/#respond Thu, 06 Jun 2019 18:30:30 +0000 https://news.mayocliniclabs.com/?p=52148 Curtis Hanson, M.D., Discusses Prognostic Markers for Chronic Lymphocytic LeukemiaCurtis Hanson, M.D., discusses the importance of detecting immunoglobulin heavy-chain variable region gene (IGHV) when acquiring prognostic and potentially therapeutic information in chronic lymphocytic leukemia (CLL) patients in CAP TODAY.

The post Curtis Hanson, M.D., Discusses Prognostic Markers for Chronic Lymphocytic Leukemia appeared first on Insights.

]]> https://news.mayocliniclabs.com/2019/06/06/curtis-hanson-m-d-discusses-prognostic-markers-for-chronic-lymphocytic-leukemia/feed/ 0 New Genetic Test Classifies Lymphomas https://news.mayocliniclabs.com/2019/04/30/new-genetic-test-classifies-lymphomas/ https://news.mayocliniclabs.com/2019/04/30/new-genetic-test-classifies-lymphomas/#respond Tue, 30 Apr 2019 15:00:32 +0000 https://news.mayocliniclabs.com/?p=50779 New Genetic Test Classifies LymphomasThe current diagnostic tools in a pathologist’s arsenal sometimes cannot provide a clear distinction between primary mediastinal large B-cell lymphoma (one of the few lymphomas more common in younger women) and diffuse large B-cell lymphoma, the most common type of non-Hodgkin’s lymphoma overall.

The post New Genetic Test Classifies Lymphomas appeared first on Insights.

]]> https://news.mayocliniclabs.com/2019/04/30/new-genetic-test-classifies-lymphomas/feed/ 0 Mayo Clinic Laboratory and Pathology Research Roundup: March 2 https://news.mayocliniclabs.com/2018/03/05/mayo-clinic-laboratory-pathology-research-roundup-march-2/ https://news.mayocliniclabs.com/2018/03/05/mayo-clinic-laboratory-pathology-research-roundup-march-2/#respond Mon, 05 Mar 2018 15:00:52 +0000 https://news.mayocliniclabs.com/?p=41076 Mayo Clinic Laboratory and Pathology Research Roundup: March 2This week’s Research Roundup highlights high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology.

The post Mayo Clinic Laboratory and Pathology Research Roundup: March 2 appeared first on Insights.

]]> https://news.mayocliniclabs.com/2018/03/05/mayo-clinic-laboratory-pathology-research-roundup-march-2/feed/ 0 B-Lymphoblastic Leukemia/Lymphoma [Algorithm] https://news.mayocliniclabs.com/2017/08/11/b-lymphoblastic-leukemialymphoma-algorithm/ https://news.mayocliniclabs.com/2017/08/11/b-lymphoblastic-leukemialymphoma-algorithm/#respond Fri, 11 Aug 2017 19:35:59 +0000 https://news.mayocliniclabs.com/?p=34558 B-Lymphoblastic Leukemia/Lymphoma [Algorithm]This algorithm can be viewed here.

The post B-Lymphoblastic Leukemia/Lymphoma [Algorithm] appeared first on Insights.

]]> https://news.mayocliniclabs.com/2017/08/11/b-lymphoblastic-leukemialymphoma-algorithm/feed/ 0